Identification and validation of molecular subtypes and prognostic models in patients with kidney cancer based on differential genes based on B cells: a multiomics analysis
Overall, we explored for the first time the profound role of B cells in kidney cancer and developed a bio-predictive model based on B cell-related genes, providing scientific guidance for personalized treatment of kidney cancer patients.
Authors
- Guangzhen Wu (ORCID: https://orcid.org/0000-0002-2300-8465)
- Jiaao Sun (ORCID: https://orcid.org/0009-0001-2379-5067)
- Qiancheng Ma (ORCID: https://orcid.org/0000-0002-3968-4310)
- Xiaochi Chen
- Feng Chen
- Shiyan Song
Institutions
- Dalian Medical University (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1186/s12885-025-13923-5
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00